1. Guest, the two part 'News in Brief' for the week beginning 16th May 2022 is here.
    Dismiss Notice
  2. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

cyclophosphamide

  1. John Mac
    Thread

    Reduced endothelial function in ME/CFS - results from open-label cyclophosphamide intervention study Fluge & Mella 2021

    Full title: Reduced endothelial function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - results from open-label cyclophosphamide...
    Thread by: John Mac, Mar 2, 2021, 20 replies, in forum: ME/CFS research
  2. Kalliope
    Thread

    Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study - 2020 - Rekeland, Mella, Fluge et al

    published in frontiers in Medicine - Family Medicine and Primary Care Results: The overall response rate by Fatigue score was 55.0% (22 of 40...
    Thread by: Kalliope, Apr 30, 2020, 129 replies, in forum: ME/CFS research
  3. Jaybee00
    Thread

    Inhibition of Upf2-Dependent Nonsense-Mediated Decay Leads to Behavioral and Neurophysiological Abnormalities by Activating the Immune Response

    https://www.cell.com/neuron/pdfExtended/S0896-6273(19)30733-0 Used cyclophosphamide to treat autism symptoms in mice by reducing brain...
    Thread by: Jaybee00, Nov 12, 2019, 10 replies, in forum: Other health news and research
  4. Cheshire
    Thread

    Øystein Fluge and Olav Mella's ME/CFS research

    Rituximab (RituxME) Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case...
    Thread by: Cheshire, Oct 22, 2017, 0 replies, in forum: Science library (Read only)
Showing results 1 to 4 of 4